Page last updated: 2024-08-26

indium and Lymphoma, B-Cell

indium has been researched along with Lymphoma, B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Endo, K; Imai, Y; Kaneta, T; Kinuya, S; Koizumi, K; Koizumi, M; Kubo, A; Nawano, S; Nishimura, T; Oriuchi, N; Terui, S; Tobinai, K; Yamaura, H	1

Other Studies

1 other study(ies) available for indium and Lymphoma, B-Cell

Article	Year
[Assessment for the image interpretation of 111In-ibritumomab tiuxetan in the phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma]. Kaku igaku. The Japanese journal of nuclear medicine, 2008, Volume: 45, Issue:2 Topics: Adult; Aged; Antibodies, Monoclonal; Clinical Trials, Phase II as Topic; Female; Humans; Indium; Indium Radioisotopes; Lymphoma, B-Cell; Male; Middle Aged; Multicenter Studies as Topic; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Recurrence	2008

Article

Year

[Assessment for the image interpretation of 111In-ibritumomab tiuxetan in the phase II study of 90Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma].

Kaku igaku. The Japanese journal of nuclear medicine, 2008, Volume: 45, Issue:2

Topics: Adult; Aged; Antibodies, Monoclonal; Clinical Trials, Phase II as Topic; Female; Humans; Indium; Indium Radioisotopes; Lymphoma, B-Cell; Male; Middle Aged; Multicenter Studies as Topic; Radioimmunotherapy; Radionuclide Imaging; Radiopharmaceuticals; Recurrence

2008